NO20000066L - 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelse - Google Patents

6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelse

Info

Publication number
NO20000066L
NO20000066L NO20000066A NO20000066A NO20000066L NO 20000066 L NO20000066 L NO 20000066L NO 20000066 A NO20000066 A NO 20000066A NO 20000066 A NO20000066 A NO 20000066A NO 20000066 L NO20000066 L NO 20000066L
Authority
NO
Norway
Prior art keywords
ylpyrindine
pyrrolidin
derivatives
preparation
pharmaceutical use
Prior art date
Application number
NO20000066A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000066D0 (no
Inventor
Alistair Lochead
Samir Jegham
Frederic Galli
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20000066D0 publication Critical patent/NO20000066D0/no
Publication of NO20000066L publication Critical patent/NO20000066L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20000066A 1997-07-09 2000-01-06 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelse NO20000066L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9708706A FR2765874B1 (fr) 1997-07-09 1997-07-09 Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
PCT/FR1998/001446 WO1999002517A1 (fr) 1997-07-09 1998-07-07 Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
NO20000066D0 NO20000066D0 (no) 2000-01-06
NO20000066L true NO20000066L (no) 2000-03-09

Family

ID=9509040

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000066A NO20000066L (no) 1997-07-09 2000-01-06 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelse

Country Status (21)

Country Link
US (1) US6184229B1 (hu)
EP (1) EP1000056A1 (hu)
JP (1) JP2002508004A (hu)
KR (1) KR20010021617A (hu)
CN (1) CN1262680A (hu)
AR (1) AR013192A1 (hu)
AU (1) AU8544498A (hu)
BG (1) BG104037A (hu)
BR (1) BR9811672A (hu)
CA (1) CA2295666A1 (hu)
CO (1) CO4890850A1 (hu)
EE (1) EE200000018A (hu)
FR (1) FR2765874B1 (hu)
HU (1) HUP0003856A2 (hu)
IL (1) IL133536A0 (hu)
NO (1) NO20000066L (hu)
PL (1) PL338123A1 (hu)
SK (1) SK212000A3 (hu)
TR (1) TR200000057T2 (hu)
WO (1) WO1999002517A1 (hu)
ZA (1) ZA986047B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005126340A (ja) * 2003-10-22 2005-05-19 Kureha Chem Ind Co Ltd 置換ピリドン類の製造法、その原料化合物及びその製造方法
US7780981B2 (en) 2004-09-13 2010-08-24 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
KR20110075044A (ko) 2007-04-02 2011-07-05 파킨슨즈 인스티튜트 처치 치료의 부작용을 감소시키기 위한 방법 및 조성물
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227391A (en) * 1992-04-10 1993-07-13 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5232933A (en) * 1992-05-21 1993-08-03 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
EE200000018A (et) 2000-08-15
AU8544498A (en) 1999-02-08
JP2002508004A (ja) 2002-03-12
TR200000057T2 (tr) 2000-08-21
FR2765874B1 (fr) 1999-08-13
EP1000056A1 (fr) 2000-05-17
CN1262680A (zh) 2000-08-09
CO4890850A1 (es) 2000-02-28
NO20000066D0 (no) 2000-01-06
WO1999002517A1 (fr) 1999-01-21
CA2295666A1 (en) 1999-01-21
FR2765874A1 (fr) 1999-01-15
HUP0003856A2 (hu) 2001-10-28
US6184229B1 (en) 2001-02-06
BG104037A (en) 2001-04-30
SK212000A3 (en) 2000-06-12
IL133536A0 (en) 2001-04-30
BR9811672A (pt) 2000-09-19
PL338123A1 (en) 2000-09-25
AR013192A1 (es) 2000-12-13
KR20010021617A (ko) 2001-03-15
ZA986047B (en) 1999-02-01

Similar Documents

Publication Publication Date Title
DK1257553T3 (da) Pyrrolopyrimidinonderivater, fremgangsmåder til fremstilling og anvendelse
DK0595851T3 (da) Fremgangsmåde til fremstilling af sertralin-mellemprodukter
DK1131315T3 (da) Polyhydroxylerede heterocykliske derivater som antikoagulanter
DK405786D0 (da) Nitromethylenderivater, deres fremstilling og anvendelse
BR9610385A (pt) Novas 4-(oxalcoxifenil)-3-óxi-piperidinas para tratamento de insuficiência cardiáca e renal
NO20045331L (no) Piperazinylacylpiperidinderivater, deres fremstilling og terapeutisk anvendelse derav
IT1232252B (it) Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
ATE356624T1 (de) Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung
DE69231445T2 (de) Triazole enthaltende antifungizide mittel
DK1222159T3 (da) Mellemprodukter til fremstilling af et benzofuran- eller benzothiophenderivat, som er nitreret i position 5, og anvendelse heraf
NO20000066L (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasøytiske anvendelse
DK0623121T3 (da) Fremstilling af N-acetylneuraminsyrederivater
ATE15890T1 (de) Ein fungizides indanylbenzamid.
NO993109L (no) Aromatiske aminderivater med NOS inhiberende effekt
DE3776044D1 (de) Pyridazinon-derivate.
NO961404L (no) 4-indolylpiperazinyl-derivater
BR9609991A (pt) Carbamoilcarboxamida composição adequada para controlar fungos nocivos processos para a preparação de uma carbamoilcarboxamida para preparação da composição e para controle de fungos nocivos e uso de um composto ou de uma composição
DK546286D0 (da) Piperidinderivater eller salte deraf og deres anvendelse som farmaceutika
DK437287D0 (da) 2,3-dihydrofuranderivater, deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af tetrahydrofuranderivater
DE69510510T2 (de) N-benzoylmethylsubstituierte paroxetinderivate
NO20000423D0 (no) Tiazolobenzoheterocykler, deres fremstilling samt medikamenter inneholdende forbindelsene
BR0206206A (pt) Derivados de etoposide e análogos, e composições farmacêuticas contendo os mesmos
SE8605458D0 (sv) 4-hydroxycoumarin derivatives
DK37582A (da) 2-pyridyloxyacetanilider,fremgangsmaade til deres fremstillingsamt deres anvendelse som herbicider
EE9900238A (et) Difenüülalküültetrahüdropüridiinid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application